A report issued by CenterWatch, a clinical trial specialty organization, showed that over 70% of all trials nationwide have difficulty recruiting patients. However, one of the major problems facing clinical trials is that patients are often unaware of the possibility of enrolling in a trial. For instance, according to The Prostate Net, more than 85% of patients did not know clinical trials were available to them.75% of these patients said they would have been willing to engage in a trial had they known it was possible. Focus groups involving the public and caregivers found that many lacked familiarity with clinical trials and were unaware of opportunities for participation.
In cases where the patient is aware of the opportunity, it is usually difficult to locate a trial or the patient may reside far from the study site. Even the largest multicenter trials can pose geographic challenges for those wishing to participate. When the patient lives within range of the study site, participation in the trial still requires significant travel time and costs. If the patient reaches the point of enrolling in a clinical trial, the extensive paperwork associated with the informed consent process can be confusing and discourage the patient from further enrolling.
Mobile health technology is eliminating this problem in a number of ways:
- Clinical Trail Awareness – Patients are able to learn about potential trials through social media and mobile health apps.
- Conducting Remote Studies – Patients are now able to qualify and participate in clinical trials without having to travel to a designated site.
- Confusion with Informed Consent – By using eQualification and eConsent, patients gain a better understanding of the requirements of the trial. Help screens and in-text definitions allows patients to have questions and concerns answered on the spot.
- Personalized Content – Interactive videos and tutorials allow patients to be educated on clinical trials through their mobile devices and content can be personalized to the patient.
Patients who feel educated about the trial they are participating in are less likely to experience confusion and will be more likely to remain as a participant for the entire study.
Parallel 6 has developed the mobile enterprise platform Clinical 6 that acknowledges these issues and creates a seamless and virtually effortless process to educate patients in a trial. If you would like to learn more about how the Clinical 6 works, please visit Parallel 6’s website and request a demo.